Six Reforms to Occupational Licensing Laws to Increase Jobs and Lower CostsPosted on July 10, 2012 | Type: Policy Report | Author: Byron Schlomach
Do you have a love of fabric, furniture, and a talent for decorating? In a few states, unless you have a license, it’s tough luck if you want to start a decorating business. Most states actually have laws that limit the use of the title “interior designer.”
The Independent Payment Advisory Board: PPACA's Anti-Constitutional and Authoritarian Super-LegislaturePosted on June 14, 2012 | Type: Policy Report | Author: Diane Cohen
When a member of Congress introduces legislation, the Constitution requires that legislative proposal to secure the approval of the House of Representatives, the Senate, and the president (unless Congress overrides a presidential veto) before it can become law. In all cases, either chamber of Congress may block it.
Ghost Busters: How to Save $125 Million a Year in Arizona's Education BudgetPosted on May 21, 2012 | Type: Policy Report | Author: Jonathan Butcher
Around the country, school finance formulas and accounting systems are notoriously complex. Arizona’s system is no exception. For many years, Arizona’s program was considered one of the nation’s most difficult to understand.
Debt and Taxes: Recommendations for ReformPosted on April 04, 2012 | Type: Policy Report | Author: Stephen Slivinski
Arizonans, through their state and local governments, are in debt to the tune of $66.5 billion. That’s over $10,000 for every man, woman, and child in the state. To put that in perspective, the average person’s income in Arizona is less than $36,000 per year.
A Pound of Cure: How Academic Detailing Could Limit Access to PharmaceuticalsPosted on March 27, 2012 | Type: Policy Report | Author: Byron Schlomach
Pharmaceutical sales are coming under criticism based on what appear to be legitimate but rare abuses of pharmaceutical salespeople promising more from a drug than they should and doctors allowing themselves to be pressured into prescribing. Unfortunately, these isolated incidents are being held up as evidence of the need for vast new government intrusion and regulation of the pharmaceutical industry’s marketing practices. While certainly well intentioned, these efforts are likely to negatively affect doctors and patients.